Why Use Computer Models for Protein Structure and Function?
Computational models provide a lens for understanding protein dynamics, complementing experimental work to connect molecular structure to biological function.
Computational models provide a lens for understanding protein dynamics, complementing experimental work to connect molecular structure to biological function.
Proteins are fundamental molecules that perform a vast array of tasks within all living organisms. Their function is intrinsically linked to their specific three-dimensional (3D) structure, which is determined by the sequence of amino acids they are made from. To understand this relationship, scientists use both experimental and computational methods. Computer-based approaches have become particularly prominent, offering powerful ways to investigate proteins at a level of detail that is often difficult to obtain through laboratory work alone.
Studying proteins is challenging due to their inherent complexity and dynamic nature. Proteins are not static objects; they are large, flexible molecules that constantly move and change their shape to carry out their biological roles. This constant motion makes them difficult to study using static pictures, as capturing these fleeting, transitional states is a significant hurdle for researchers.
Traditional experimental methods for determining protein structure have notable limitations. X-ray crystallography, which has been used to determine the majority of known protein structures, requires the protein to form a well-ordered crystal. This process can be difficult, and many proteins, particularly those embedded in cell membranes, resist crystallization. The act of crystallization can also lock the protein into a single, static conformation that doesn’t fully represent its dynamic behavior in a natural environment.
Another technique, Nuclear Magnetic Resonance (NMR) spectroscopy, can study proteins in a more natural solution state and provide insights into their flexibility. However, NMR is limited to smaller proteins, as the signals from larger molecules become too complex to interpret. Both methods are also time-consuming and expensive, requiring large amounts of purified protein. These experimental bottlenecks create a large gap between the number of known protein sequences and determined 3D structures, which computational methods are helping to close.
Computational modeling provides tools that allow scientists to explore proteins in ways that complement and extend laboratory experiments. These methods help answer questions ranging from determining a protein’s shape to simulating its functional movements and interactions. By using these models, researchers can build and manipulate detailed models to generate and test new hypotheses about protein function.
A significant breakthrough is the ability to predict a protein’s 3D structure directly from its amino acid sequence. Artificial intelligence (AI) systems like AlphaFold have revolutionized this field. By training on the vast database of experimentally determined protein structures, these AI tools can predict the shape of a new protein with high accuracy. This provides scientists with immediate structural information for proteins that are difficult to study in the lab, accelerating research into their roles in health and disease.
Beyond static structure prediction, molecular dynamics (MD) simulations allow scientists to watch proteins in motion. These simulations use the principles of physics to model the movements and interactions of every atom in a protein over time. This “computational microscope” can reveal how a protein flexes, changes shape when interacting with another molecule, or unfolds. MD simulations help in understanding the physical basis of a protein’s stability and function, providing a view of dynamic processes often invisible to experimental techniques.
Computer models are also used to study how proteins interact with other molecules, a process known as molecular docking. These programs can predict how a small molecule, like a potential drug, might fit into a specific pocket on a protein’s surface and how tightly it will bind. Models can also simulate how two proteins bind to each other to form a larger functional complex. By screening thousands of compounds virtually, docking helps scientists prioritize which molecules are most promising for lab testing.
Computational tools are also adept at predicting the consequences of mutations, or changes in a protein’s amino acid sequence. By altering the sequence in a computer model, researchers can forecast whether a specific mutation might disrupt the protein’s fold, stability, or ability to interact with other molecules. This is useful for understanding the molecular basis of genetic diseases. These predictive capabilities help link genetic information to functional outcomes.
The integration of computational models into protein research offers several advantages over relying solely on laboratory methods. These benefits relate to speed, cost, and the ability to investigate phenomena that are otherwise inaccessible. This makes computational work a powerful partner to wet-lab experimentation, where each approach informs and strengthens the other.
A primary advantage is speed and efficiency. While determining a single protein structure experimentally can take months or years, a high-quality structural model can often be generated by a computer in hours or days. This allows researchers to rapidly screen through many different proteins or mutations to identify the most interesting candidates for more time-consuming experimental follow-up.
Computational approaches are also cost-effective. Wet-lab experiments require expensive chemical reagents, specialized equipment, and significant labor. In contrast, running simulations on a computer cluster can bypass many of these costs, particularly in the early phases of a project. By pre-screening ideas on the computer, labs can focus their experimental resources on the most promising avenues.
A unique benefit of computer modeling is its ability to explore the “unobservable.” Scientists can use simulations to study protein conformations that are too short-lived to be captured experimentally, such as the transition state of a chemical reaction. They can also model conditions that would be difficult to create in the lab, like extreme temperatures, or test the effects of theoretical drug molecules that have not yet been synthesized.
The application of computational protein modeling extends beyond basic research, with tangible impacts on medicine, biotechnology, and our understanding of disease. These tools are used in the development of new therapies and industrial products. By providing a detailed, atomic-level view of molecular interactions, computer models help bridge the gap between biological information and practical solutions.
In drug discovery and development, computational modeling is a standard tool used to identify and validate new therapeutic targets. For example, once a protein is identified as playing a role in a disease, docking simulations can screen vast libraries of chemical compounds to find ones that might inhibit that protein’s activity. This process was used in developing drugs like neuraminidase inhibitors for influenza. Modeling also helps researchers optimize drug candidates by predicting how chemical modifications might improve their binding affinity or reduce side effects.
Computational methods are also advancing our understanding of diseases caused by protein misfolding, such as Alzheimer’s and Parkinson’s. In these conditions, specific proteins fail to adopt their correct shape and instead form toxic aggregates that damage nerve cells. Simulations can help reveal the molecular triggers for this misfolding process and provide clues about how it might be prevented. This knowledge is being used to design new therapeutic strategies aimed at stabilizing proteins in their healthy state.
Beyond medicine, protein engineering leverages computational design to create novel proteins with customized functions for industrial and biotechnological applications. For instance, scientists can redesign enzymes to make them more efficient catalysts for producing biofuels or more stable for use in laundry detergents. Computational design has also been used to create synthetic protein scaffolds for delivering drugs or to develop new vaccines, such as those targeting viruses like SARS-CoV-2.